 TRILEPTAL
|
Novartis
|
| oxcarbazepina |
Anticonvulsivo |
| 300 mg comp.x 30 | $55.130,07 | (19/12/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $8.887,73 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $38.805,74 AF $16.324,33 |
|
|
|
|
| 300 mg comp.x 60 | $91.813,62 | (19/12/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $15.899,29 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $67.585,95 AF $24.227,67 |
|
|
|
|
| 600 mg comp.x 30 | $106.124,23 | (19/12/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $17.108,63 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $38.805,74 AF $67.318,49 |
|
|
|
|
| 600 mg comp.x 60 | $180.749,24 | (19/12/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $29.139,08 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $67.585,95 AF $113.163,29 |
|
|
|
|
| jbe.x 100 ml | $34.428,92 | (19/12/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $5.550,17 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $20.354,61 AF $14.074,31 |
|
|
|
|
| |
